Skip to main content

Month: May 2021

Swiss Water Announces $25 Million Financing for the Construction of Its Second Line of Production (Titan 2) at Its Delta, BC Facility

VANCOUVER, British Columbia, May 24, 2021 (GLOBE NEWSWIRE) — Swiss Water Decaffeinated Coffee Inc. (TSX – SWP) (“Swiss Water” or “the Company”) is pleased to announce an amendment to the existing senior debt facility with the Company’s senior lender, Business Development Bank of Canada, with participation by a new lender, Farm Credit Canada, which would provide the Company with up to an additional $25 million of senior debt financing at an interest rate of approximately four percent per annum and a favourable payment and amortization schedule by increasing the senior debt facility to $45 million from the current $20 million (the “Amended Senior Facility”). The incremental funds available under the Amended Senior Facility, together with the Company’s existing available credit and projected internally generated cash flow, are anticipated...

Continue reading

Notice to Disregard — Micron Technology, Inc.

MANASSAS, Va., May 24, 2021 (GLOBE NEWSWIRE) — We are advised by Micron Technology, Inc. that journalists and other readers should disregard the news release, “Micron Hosts U.S. Secretary of Commerce, Congressional and Local Leaders at its State-of-the-Art Manassas, Virginia Fabrication Facility” issued at 6:24 p.m. PT, May 24, 2021, over GlobeNewswire. Please refer to the updated version issued at 8:15 p.m. PT, May 24, 2021. Updated version: https://investors.micron.com/news-releases/news-release-details/micron-hosts-us-secretary-commerce-and-congressional-and-local 

Continue reading

Micron Hosts U.S. Secretary of Commerce and Congressional and Local Leaders at its State-of-the-Art Manassas, Virginia Fabrication Facility

Micron Technology, Inc. hosted government officials for a tour of its Manassas, Va. advanced manufacturing facility.From L-R, Micron President and CEO Sanjay Mehrotra, U.S. Senator John Cornyn (R-TX), U.S. Secretary of Commerce Gina Raimondo, Manassas Mayor Michelle Davis-Younger and U.S. Senator Mark R. Warner (D-VA).MANASSAS, Va., May 24, 2021 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU), today hosted U.S. Secretary of Commerce Gina Raimondo and Congressional and local officials for a tour of its Manassas, Va., advanced manufacturing facility. The visit underscored the importance of domestic semiconductor manufacturers, and highlighted Micron’s position in the industry as the only manufacturer of memory and storage products in the U.S. Secretary Raimondo was joined by U.S. Senators John Cornyn (R-TX)...

Continue reading

Micron Hosts U.S. Secretary of Commerce, Congressional and Local Leaders at its State-of-the-Art Manassas, Virginia Fabrication Facility

Micron Technology, Inc. hosted government officials for a tour of its Manassas, Va. advanced manufacturing facility.Micron Technology, Inc. hosted government officials for a tour of its Manassas, Va. advanced manufacturing facility. From L-R, Micron President and CEO Sanjay Mehrotra, Senator John Cornyn (R-TX), U.S. Secretary of Commerce Gina Raimondo, Manassas Mayor Michelle Davis-Younger and Senator Mark Warner (D-VA).MANASSAS, Va., May 24, 2021 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU), today hosted U.S. government officials for a tour of its Manassas, VA, advanced manufacturing facility. The visit underscored the importance of Micron’s position in the industry as the only manufacturer of memory and storage products in the U.S. In attendance were Secretary of Commerce Gina Raimondo, Senators...

Continue reading

First Patient Dosed in Japanese Prostate Cancer Imaging Study

MELBOURNE, Australia and KYOTO, Japan, May 25, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a clinical study in Japan using Telix’s investigational prostate cancer imaging product TLX591-CDx (Illuccix®, Kit for the preparation of 68Ga-PSMA-11 injection). The study is an academic collaboration between Telix and Kanazawa University. The study will enroll ten patients with advanced prostate cancer and is the first clinical evaluation of gallium-based PSMA imaging in Japan. The objective is to obtain safety data in a representative Japanese patient population, and to demonstrate that the targeting and biodistribution of TLX591-CDx in Japanese patients is consistent with international experience. Clinical data may facilitate development...

Continue reading

TLX66 Meets Study Objectives in Patients with AL Amyloidosis

MELBOURNE, Australia and SOUTHAMPTON, United Kingdom, May 25, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Company’s bone marrow conditioning investigational candidate TLX66 (90Y-besilesomab) has met study objectives, demonstrating the initial safety profile in patients with Systemic Amyloid Light Chain Amyloidosis (AL amyloidosis). The TRALA trial (Targeted Radiotherapy for AL Amyloidosis) is a Phase I/IIa trial to evaluate the safety and toxicity of TLX66 as the sole bone marrow conditioning agent prior to autologous hematopoietic stem cell transplantation (HSCT) in patients with AL amyloidosis.1 The TRALA trial was sponsored by University Hospital Southampton in Southampton U.K. and run across four centres: Southampton, University College Hospital London, Royal...

Continue reading

Industry Veteran John Charman to retire from Sompo International; James Shea to succeed him as Executive Chairman and Chief Executive Officer

PEMBROKE, Bermuda, May 24, 2021 (GLOBE NEWSWIRE) — Sompo International Holdings Ltd., a Bermuda-based specialty provider of property and casualty insurance and reinsurance, announced today that after 8 years with the company and over five decades of unparalleled success in the industry, John Charman will retire from Sompo International at the end of his current contract in April 2022. James Shea has been selected to succeed Mr. Charman in his role of Executive Chairman of the Board of Directors, Sompo International Holdings Ltd. and Chief Executive Officer of Overseas Insurance and Reinsurance Business, Sompo Holdings, Inc. In addition, he will be appointed Chief Executive Officer of Sompo International Holdings. All of Mr. Shea’s appointments will be effective September 1, 2021, subject to regulatory approvals. He will report...

Continue reading

Jushi Holdings Inc. Provides Update on Financial Statement Filings

BOCA RATON, Fla., May 24, 2021 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF), a vertically integrated, multi-state cannabis operator, is providing an update with respect to the filing of the Company’s audited annual financial statements for the year ended December 31, 2020, the related management’s discussion and analysis, related CEO and CFO certificates and annual information form for the year ended December 31, 2020 (collectively, the “Documents”). As of Friday, May 21, 2021, the Company’s auditor, MNP, indicated that they were doing their best to enable the Company to file the Documents with the Canadian securities regulators today. The Company and MNP now expect to complete the audit and the filing of the Documents by May 28, 2021. The audit is substantially complete, pending...

Continue reading

AgEagle Aerial Systems Appoints Drone Industry Leader Brandon Torres Declet as New Chief Executive Officer

WICHITA, Kan., May 24, 2021 (GLOBE NEWSWIRE) — AgEagle™ Aerial Systems Inc. (NYSE American: UAVS) (“AgEagle” or the “Company”), an industry leading drone solutions provider, today announced that its Board of Directors has named Brandon Torres Declet, current Chief Operating Officer of the Company, as its new Chief Executive Officer, effective immediately. He is succeeding J. Michael Drozd who has elected to leave AgEagle to pursue new career opportunities. Barrett Mooney, Chairman of the Board, stated, “Brandon is a proven leader with a distinguished track record of entrepreneurial success, innovation and talent development, as well as deep knowledge, influence and experience in the drone industry. After careful consideration, the Board determined that the change in leadership was a great opportunity to leverage Brandon’s expertise...

Continue reading

Dentsply Sirona to Present at Four Upcoming Virtual Investor Conferences

CHARLOTTE, N.C., May 24, 2021 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), The Dental Solutions Company, today announced the Company will present at four investor conferences in June.William Blair 41st Annual Growth Stock Conference on June 2, 2021 at 9:40am ET Stifel 2021 Virtual Jaws & Paws Conference on June 3, 2021 at 10:00am ET Goldman Sachs 42nd Annual Global Healthcare Conference on June 9, 2021 at 9:40am ET Baird 2021 Healthcare ESG Symposium on June 17, 2021 at 10:40am ETInvestors and other interested parties will be able to access a live audio webcast of the presentations by visiting the Investors section of the Dentsply Sirona website: Upcoming Events. A replay of the webcasts will also be available for a period of time within the Investors section of the Dentsply Sirona website:...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.